Akcea Therapeutics Inc. (AKCA) Tumbled -7.48% or -2.52 To Price $31.16 On Tuesday


Akcea Therapeutics Inc. (AKCA) tumbled -7.48% or -2.52 to $31.16. It is about 261677 shares traded, which is 67.5% compare to the average total volume 387671. The market cap of AKCA is $2.67 billion. The year to date change is 86.3%. The 52 week price range is from $15.2 to $40.75. Price of AKCA have changed -9.41% during last week. It have changed 27.38% over last month, 33.07% over last 3 months, 30.69% over last 6 months and 19.94% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AKCA is 31.26. It is 0.32% above current price. The stock faces resistance at 50-day moving averages. The 200-day Moving Averages for AKCA is 24.89. It is -20.12% below current price. The 52-week High is 40.75. It is 30.78% from the current price. The 52-week Low is 15.2. It is -51.22% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of AKCA is 22.4 on 2018-09-14. Short % to float is 9.94%. There are some statistics of AKCA. It is has market cap $2.67 billion. The share outstanding is 85.72 million. The average volume is 387671. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AKCA is -227.00%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AKCA is -44.91%.


Tags:

Share this post